{
    "nctId": "NCT02281149",
    "briefTitle": "Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:",
    "officialTitle": "Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: Evaluation of the Toxicity and Quality of Life",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "acute and tardive toxicity according to NCI-CTCAE v4.0",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1-Patient with breast cancer proved by histology and treated surgically 2. Relevant of adjuvant radiotherapy after partial or total mastectomy with or without lymph node irradiation 3- Age \u2265 18 years 4- Information and no opposition to the patient\n\nExclusion Criteria:\n\n1. - Metastatic disease\n2. - Patient having another severe disease or uncontrolled which could jeopardize the trial participation\n3. - pregnant or breastfeeding woman 4-inability to do follow-up medical care of clinical trial for geographical, social or psychological reasons",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}